HIPAA Alert: Potential Data Breach Learn More
Questions on Oncology, Hematology and/or Infusion Clinical Services due to COVID-19 Crisis – CALL 833-698-1623
Important Information for Our Patients Regarding the Coronavirus.
RCCA Providing Area Cancer Patients with Access to Care During Coronavirus Outbreak
RCCA Offering Patients Virtual Visits During Coronavirus Pandemic
Regional Cancer Care Associates treats patients with a number of blood disorders unrelated to cancer. These conditions include anemia, clotting disorders, and bleeding disorders. We pride ourselves on our ability to offer state-of-the-art services in community-based care centers, and taking a personalized approach to patient care. With convenient locations in New Jersey, Connecticut, Maryland, and the Washington, DC area, Regional Cancer Care Associates patients are able to receive the hematology care they need in a care center close to home.
We’re here for you. Call us at 844-346-7222 or
Hematology covers a wide range of blood disorders, including both benign (non-cancerous) and cancerous conditions. The symptoms of benign hematologic conditions depend on several factors, such as platelet count and iron absorption. Common symptoms of a blood disorder may include:
Some benign blood conditions can be managed through lifestyle changes and medication. Some may only need treatment during pregnancy, while others are inherited and require ongoing care. Our comprehensive diagnostic testing services help our physicians determine the best course of treatment for each patient.
At Regional Cancer Care Associates, our benign hematology services cover a wide range of disorders. Common blood disorders that we treat at each of our locations include the following:
Anemia is characterized by a low red blood count and is often accompanied by fatigue. The condition can stem from several issues, but common causes include iron deficiency and chronic disease.
Hemolytic anemia, a more complex form of the condition, is marked by the breakdown of red blood cells. Other forms of anemia and related conditions that RCCA treats include:
Usually triggered by an injury, blood clotting is the body’s natural defense against excessive bleeding. Clots form when proteins and particles in the blood (platelets) adhere together. However, certain conditions may exacerbate this natural process. Blood clotting disorders include:
Bleeding disorders that inhibit clotting can cause excessive bleeding after injury or surgery. These conditions may be present from birth or develop at a later stage in life. Conditions include:
Abnormal platelet function can cause issues with blood clotting, bruising, and bleeding. Thrombocytosis is a blood disorder in which the body produces platelets in excess, while thrombocytopenia occurs when the body produces low amounts of platelets. Related conditions include:
Often hereditary, hemochromatosis causes the body to absorb too much iron from food. Because iron is stored in the organs, too much of this mineral can lead to complications.
RCCA offers cutting-edge treatment options for every type of cancer. Our expert care teams can match you with the treatment plan that fits your needs. LEARN MORE
Improve your quality of life and learn to manage life with cancer through our integrative services. We offer several solutions to support and promote physical, mental, emotional, and spiritual health. LEARN MORE
The field of cancer treatment is constantly improving and evolving. RCCA conducts hundreds of clinical trials that can help develop new therapies and treatment plans. LEARN MORE
If you need near-term or ongoing care for anemia or another benign blood disorder, schedule an appointment at Regional Cancer Care Associates. Patients have access to a full range of services across New Jersey, Connecticut, Maryland, and the Washington, DC area, making it easy to find a location convenient for you. Contact us today to learn more about our benign hematology services.
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.